1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Preclinical Imaging Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Preclinical Imaging by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Preclinical Imaging by Country/Region, 2018, 2022 & 2029
2.2 Preclinical Imaging Segment by Type
2.2.1 Optical Imaging Systems
2.2.2 Nuclear Imaging Systems
2.2.3 Micro-MRI Systems
2.2.4 Micro-Ultrasound Systems
2.2.5 Micro-CT Systems
2.2.6 Preclinical Photoacoustic Imaging Systems
2.2.7 Preclinical Magnetic Particle Imaging (MPI) Systems
2.3 Preclinical Imaging Sales by Type
2.3.1 Global Preclinical Imaging Sales Market Share by Type (2018-2023)
2.3.2 Global Preclinical Imaging Revenue and Market Share by Type (2018-2023)
2.3.3 Global Preclinical Imaging Sale Price by Type (2018-2023)
2.4 Preclinical Imaging Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics Centers
2.4.3 Others
2.5 Preclinical Imaging Sales by Application
2.5.1 Global Preclinical Imaging Sale Market Share by Application (2018-2023)
2.5.2 Global Preclinical Imaging Revenue and Market Share by Application (2018-2023)
2.5.3 Global Preclinical Imaging Sale Price by Application (2018-2023)
3 Global Preclinical Imaging by Company
3.1 Global Preclinical Imaging Breakdown Data by Company
3.1.1 Global Preclinical Imaging Annual Sales by Company (2018-2023)
3.1.2 Global Preclinical Imaging Sales Market Share by Company (2018-2023)
3.2 Global Preclinical Imaging Annual Revenue by Company (2018-2023)
3.2.1 Global Preclinical Imaging Revenue by Company (2018-2023)
3.2.2 Global Preclinical Imaging Revenue Market Share by Company (2018-2023)
3.3 Global Preclinical Imaging Sale Price by Company
3.4 Key Manufacturers Preclinical Imaging Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Preclinical Imaging Product Location Distribution
3.4.2 Players Preclinical Imaging Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Preclinical Imaging by Geographic Region
4.1 World Historic Preclinical Imaging Market Size by Geographic Region (2018-2023)
4.1.1 Global Preclinical Imaging Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Preclinical Imaging Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Preclinical Imaging Market Size by Country/Region (2018-2023)
4.2.1 Global Preclinical Imaging Annual Sales by Country/Region (2018-2023)
4.2.2 Global Preclinical Imaging Annual Revenue by Country/Region (2018-2023)
4.3 Americas Preclinical Imaging Sales Growth
4.4 APAC Preclinical Imaging Sales Growth
4.5 Europe Preclinical Imaging Sales Growth
4.6 Middle East & Africa Preclinical Imaging Sales Growth
5 Americas
5.1 Americas Preclinical Imaging Sales by Country
5.1.1 Americas Preclinical Imaging Sales by Country (2018-2023)
5.1.2 Americas Preclinical Imaging Revenue by Country (2018-2023)
5.2 Americas Preclinical Imaging Sales by Type
5.3 Americas Preclinical Imaging Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preclinical Imaging Sales by Region
6.1.1 APAC Preclinical Imaging Sales by Region (2018-2023)
6.1.2 APAC Preclinical Imaging Revenue by Region (2018-2023)
6.2 APAC Preclinical Imaging Sales by Type
6.3 APAC Preclinical Imaging Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Preclinical Imaging by Country
7.1.1 Europe Preclinical Imaging Sales by Country (2018-2023)
7.1.2 Europe Preclinical Imaging Revenue by Country (2018-2023)
7.2 Europe Preclinical Imaging Sales by Type
7.3 Europe Preclinical Imaging Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Preclinical Imaging by Country
8.1.1 Middle East & Africa Preclinical Imaging Sales by Country (2018-2023)
8.1.2 Middle East & Africa Preclinical Imaging Revenue by Country (2018-2023)
8.2 Middle East & Africa Preclinical Imaging Sales by Type
8.3 Middle East & Africa Preclinical Imaging Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Preclinical Imaging
10.3 Manufacturing Process Analysis of Preclinical Imaging
10.4 Industry Chain Structure of Preclinical Imaging
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Preclinical Imaging Distributors
11.3 Preclinical Imaging Customer
12 World Forecast Review for Preclinical Imaging by Geographic Region
12.1 Global Preclinical Imaging Market Size Forecast by Region
12.1.1 Global Preclinical Imaging Forecast by Region (2024-2029)
12.1.2 Global Preclinical Imaging Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Preclinical Imaging Forecast by Type
12.7 Global Preclinical Imaging Forecast by Application
13 Key Players Analysis
13.1 Perkinelmer
13.1.1 Perkinelmer Company Information
13.1.2 Perkinelmer Preclinical Imaging Product Portfolios and Specifications
13.1.3 Perkinelmer Preclinical Imaging Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Perkinelmer Main Business Overview
13.1.5 Perkinelmer Latest Developments
13.2 Bruker
13.2.1 Bruker Company Information
13.2.2 Bruker Preclinical Imaging Product Portfolios and Specifications
13.2.3 Bruker Preclinical Imaging Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bruker Main Business Overview
13.2.5 Bruker Latest Developments
13.3 Fujifilm
13.3.1 Fujifilm Company Information
13.3.2 Fujifilm Preclinical Imaging Product Portfolios and Specifications
13.3.3 Fujifilm Preclinical Imaging Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Fujifilm Main Business Overview
13.3.5 Fujifilm Latest Developments
13.4 Mediso
13.4.1 Mediso Company Information
13.4.2 Mediso Preclinical Imaging Product Portfolios and Specifications
13.4.3 Mediso Preclinical Imaging Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mediso Main Business Overview
13.4.5 Mediso Latest Developments
13.5 Milabs
13.5.1 Milabs Company Information
13.5.2 Milabs Preclinical Imaging Product Portfolios and Specifications
13.5.3 Milabs Preclinical Imaging Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Milabs Main Business Overview
13.5.5 Milabs Latest Developments
13.6 MR Solutions
13.6.1 MR Solutions Company Information
13.6.2 MR Solutions Preclinical Imaging Product Portfolios and Specifications
13.6.3 MR Solutions Preclinical Imaging Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 MR Solutions Main Business Overview
13.6.5 MR Solutions Latest Developments
13.7 Aspect Imaging
13.7.1 Aspect Imaging Company Information
13.7.2 Aspect Imaging Preclinical Imaging Product Portfolios and Specifications
13.7.3 Aspect Imaging Preclinical Imaging Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Aspect Imaging Main Business Overview
13.7.5 Aspect Imaging Latest Developments
13.8 Li-Cor Biosciences
13.8.1 Li-Cor Biosciences Company Information
13.8.2 Li-Cor Biosciences Preclinical Imaging Product Portfolios and Specifications
13.8.3 Li-Cor Biosciences Preclinical Imaging Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Li-Cor Biosciences Main Business Overview
13.8.5 Li-Cor Biosciences Latest Developments
13.9 Trifoil Imaging
13.9.1 Trifoil Imaging Company Information
13.9.2 Trifoil Imaging Preclinical Imaging Product Portfolios and Specifications
13.9.3 Trifoil Imaging Preclinical Imaging Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Trifoil Imaging Main Business Overview
13.9.5 Trifoil Imaging Latest Developments
13.10 Miltenyi Biotec
13.10.1 Miltenyi Biotec Company Information
13.10.2 Miltenyi Biotec Preclinical Imaging Product Portfolios and Specifications
13.10.3 Miltenyi Biotec Preclinical Imaging Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Miltenyi Biotec Main Business Overview
13.10.5 Miltenyi Biotec Latest Developments
14 Research Findings and Conclusion
| ※参考情報 前臨床画像処理とは、医療および生物医学分野において、主に新しい治療法や薬剤の効果を評価するために用いられる技術です。前臨床研究は、ヒトでの臨床試験に進む前に、動物モデルを用いて行われます。この段階では、病気のメカニズムを理解し、新しい医療技術の有効性や安全性を確認するための重要なデータを得ることを目的としています。 前臨床画像処理の特徴の一つは、その非侵襲性です。動物モデルを使用して実施されるため、画像処理は動物に対する負担を最小限に抑えつつ、内部の状態を詳細に観察することを可能にします。これにより、研究者は生体内での生理的、病理的なプロセスをリアルタイムで捉え、動物の健康状態や治療の進行状況を把握することができます。 前臨床画像処理にはいくつかの種類があります。例えば、X線画像、MRI（磁気共鳴画像）、CT（コンピュータ断層撮影）、PET（陽電子放射断層撮影）、SPECT（単一光子放射断層撮影）などの技術が含まれます。これらの各技術は、異なる特性と利点を持ち、使用する目的や動物モデルに応じて選択されます。 X線画像は、骨や腫瘍の位置、形状を確認するために用いられる最も一般的な方式です。単純な構造を持つ対象に対しては非常に効果的ですが、軟部組織の詳細な情報を得るには限界があります。逆にMRIは、ソフトティッシュのコントラストが高いため、脳や内臓、腫瘍の評価に非常に有用です。 CTは、X線を用いた断層画像を作成する方法で、特に内部の構造を三次元的に詳細に観察することができ、大きな腫瘍の検出や、病変の評価に役立ちます。PETは放射性トレーサーを用いて生理学的活動を評価するため、がん細胞がどれだけ活発に機能しているかを判断するために特化されています。一方、SPECTは特定の薬剤の挙動を追跡するために用いられ、薬剤の分布や作用メカニズムを理解するために重要な役割を果たします。 前臨床画像処理の用途は多岐にわたります。新薬の開発過程においては、薬剤の生体内動態や生理的変化を観察するために利用されます。また、がん研究においては、腫瘍の成長や治療効果を評価する手段として欠かせないものとなっています。さらに、心血管疾患や神経疾患などのさまざまな病気のメカニズムを探るためにも広く使用されています。 関連技術としては、画像処理アルゴリズムや人工知能（AI）の利用があります。前臨床画像では、得られたデータから迅速かつ正確に情報を抽出する必要があります。そのため、画像解析技術が発展しており、AIを活用することで、より高精度な分析が可能になっています。AIは、パターン認識や予測モデルの構築に寄与し、従来の解析法に比べて大幅に効率化を図ることができます。 前臨床画像処理は、医学研究における重要な要素です。この技術の発展により、新たな診断法や治療法の開発が進み、人々の健康に寄与しているのです。今後も、技術革新が期待される分野であり、新たな研究開発によって、さらなる前進が見込まれます。前臨床画像処理は、医療の未来を支える基盤となるでしょう。 |
